Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial

ObjectivesA breakthrough seizure is one occurring after at least 12 months seizure freedom while on treatment. The Driver and Vehicle Licensing Agency (DVLA) allows an individual to return to driving once they have been seizure free for 12 months following a breakthrough seizure. This is based on th...

Full description

Saved in:
Bibliographic Details
Published in:BMJ open 2017-07, Vol.7 (7), p.e015868-e015868
Main Authors: Bonnett, L J, Powell, G A, Tudur Smith, C, Marson, AG
Format: Article
Language:English
Subjects:
Adult
Age
Anticonvulsants - therapeutic use
Automobile Driving
Convulsions & seizures
Drug dosages
Epidemiology
Epilepsy
Epilepsy - complications
Epilepsy - drug therapy
Evidence-based medicine
Female
Humans
Kaplan-Meier Estimate
Legislation
Male
Middle Aged
Neurology
Patients
Proportional Hazards Models
Recurrence
Remission Induction
Risk Assessment
Seizures - epidemiology
Substance abuse treatment
Time Factors
United Kingdom
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ObjectivesA breakthrough seizure is one occurring after at least 12 months seizure freedom while on treatment. The Driver and Vehicle Licensing Agency (DVLA) allows an individual to return to driving once they have been seizure free for 12 months following a breakthrough seizure. This is based on the assumption that the risk of a further seizure in the next 12 months has dropped
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2017-015868